Drug Database
Back to search

Iceland· IS-EU/1/15/989/002

Tenkasi

A oritavancin product containing oritavancinum inn dífosfat, registered in Iceland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 12 of our 19 countries.

ATC J01XA05

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedTenkasiATCJ01XA05REGISTER NO.IS-EU/1/15/989/002PACKS LISTED0CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oritavancinum inn dífosfatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oritavancin is registered in 12 of 19 countries.

Countries holding a registration under ATC J01XA05 (oritavancin), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 8 of them publish a price we can compare per daily dose
Search oritavancin products by name

Oritavancin · ATC J01XA05

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Oritavancinum INN dífosfat
Manufacturer
Menarini International Operations Luxembourg S.A.
Country
Iceland (IS)
ATC code
J01XA05
ATC class
Oritavancin
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for oritavancin.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oritavancin against other medicinesHow interaction checks work

Oritavancin · interactions on record

68 records

  • 2 severe
  • 64 moderate
  • 2 minor

Most severe, free to view

  • HeparinB01AB01severe
  • HeparinB05CX05severe
  • Sodium picosulfateA06AB08moderate
  • NitisinoneA16AX04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01XA05

Oritavancin, as other registers publish it.

All oritavancin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3ce122e-2dd4-43a2-bf9d-a8157d0a15a6
GET /v1/drugs/f3ce122e-2dd4-43a2-bf9d-a8157d0a15a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stofn fyrir innrennslisþykkni, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "J01XA05",
  "marketed": false,
  "strength": "1200 mg",
  "ma_number": "EU/1/15/989/002",
  "substance": "Oritavancinum INN dífosfat",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "45184"
}
API referenceMCP serverPlans

See everything about oritavancin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console